Trials / Terminated
TerminatedNCT01779466
Daytime Impact Sleep Study
A Double-blind, Randomised, Parallel-group Trial Investigating Sleep Behaviour and Daytime Performance in Nocturia Patients Treated With Desmopressin Orally Disintegrating Tablets as Compared to Placebo
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This trial will investigate the relationship of sleep, daytime performance and nocturia in patients treated with Desmopressin or placebo. Male and Female patients will be administered Desmopressin or Placebo every day for 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desmopressin | |
| DRUG | Placebo (not active) |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2013-01-30
- Last updated
- 2015-04-27
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01779466. Inclusion in this directory is not an endorsement.